Drug developpment Drug developpment
Select your search
Contact us

AntiCancer Pharmacology

AntiCancer Pharmacology Bertin Pharma

Bertin Pharma is able to evaluate the efficacy of new anticancer candidates, chemical substances (i.e. drugs) but also vaccine, gene therapy, alone or with partners.

Our Unique Integrated Offer

Our strong partnership with Oncodesign and CERB allows us to propose an integrated offer, for example in vivo imaging for mice and rats but also other animal species such as the rabbit.

AntiCancer Molecules Analysis

Nucleoside derivatives remain one important part of anticancer therapy and, as antiviral nucleoside derivatives, their pharmacological efficiency is related to their intracellular phosphorylation.

Bertin Pharma is able to quantify Anticancer Molecules and especially triphosphorylated derivatives of anticancer nucleoside derivatives e.g. Gemcitabine and, anticancer gene therapy and their level of integration in cell genome.

This capacity allows :

  • optimization of dosages, dosing schedules & combination therapy,
  • evaluation of drug resistance mechanisms, and
  • biodistribution & safety of gene therapies.


Bertin Pharma - Drug developpment

Follow Us

Linkedin Youtube Twitter Google+

Contact us

Any project? Any challenge? We are in!
+33 (0) 139 306 260
Any questions? Contact us

Parc d’Activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux - France
View our other locations


Do you want to be kept updated with Bertin Pharma's latest news?

Manage my subscriptions